The role of phosphoinositide 3-kinase pathway inhibitors in the treatment of lung cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17671156.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The phosphoinositide 3-kinase signaling network is widely implicated in the pathogenesis of human cancer. This pathway is commandeered by cancer cells to promote unrestrained cellular growth and survival. In this brief review, we speculate about the uses of inhibitors of phosphoinositide 3-kinase signaling as treatments for human cancers, with an emphasis on non-small cell lung cancer.
Medical subject headings
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Phosphoinositide-3 Kinase Inhibitors
- Protein Kinase Inhibitors